# DESCRIPTION

## FIELD OF THE INVENTION

- define field of invention

## BACKGROUND OF THE INVENTION

- motivate cancer diagnosis
- limitations of current diagnosis
- describe non-Hodgkin's lymphoma
- describe canine lymphoma

## SUMMARY OF THE INVENTION

- introduce immunosignature method
- motivate single blood test
- describe utility of serological test
- describe ideal biomarker
- introduce immunosignaturing technology

## DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

- introduce experimental design and results

### FDR The Benjamani and Hochberg False Discovery Rate Correction

- define abbreviations
- describe experimental design
- outline results and conclusions
- describe serum sample collection
- describe peptide microarrays
- describe binding sera to immunosignature arrays
- describe statistical analysis
- describe results: study plan
- describe immunosignature distinguishing canine lymphoma patients from healthy dogs
- describe heatmap in FIG. 1A
- describe PCA in FIG. 1B
- describe ROC curve in FIG. 1C
- describe immunosignature predicting health status in an independent set of dogs
- describe FIG. 2
- describe iterative testing
- describe Table 2
- describe exclusion of other factors
- describe immunosignature distinguishing dogs with T cell lymphoma from those with B cell lymphoma
- describe heatmap in FIG. 3A
- describe PCA in FIG. 3B
- describe ROC curve in FIG. 3C
- describe characterization of individual lymphoma immunosignature
- describe pattern matching analysis
- describe heatmap of unique peptides in FIG. 4a
- describe sequence motifs in FIG. 4b & c
- describe monitoring immunosignature present at diagnosis
- describe changes in individual immunosignatures
- describe subtype immunosignature
- describe further characterization of B cell lymphoma immunosignature
- describe median raw feature intensity
- describe entropy measures
- describe FIG. 5a & b
- describe immunosignature of B cell LSA at diagnosis
- describe heatmap in FIG. 6a
- describe PCA in FIG. 6b
- describe ROC curve in FIG. 6c
- describe discussion
- describe lymphoma as a clonal disease
- describe individualized immunosignatures
- describe class immunosignature
- describe influence of antibody produced by individual B cell clone
- describe observation of personalized immunosignature
- describe conversion of microarray-based assay to diagnostic
- describe robustness of platform
- describe practical diagnostic assay
- describe kit for diagnosing canine lymphoma
- describe improvement over current veterinary serodiagnostics

